Leonard Zehr, Author at BioTuesdays

This Week's Feature

InspireMD advancing global distribution of CGuard EPS carotid stent for stroke prevention; gearing for U.S. pivotal trial

InspireMD (NYSE American:NSPR) is awaiting a decision from the FDA for an investigational device exemption as a steppingstone for a pivotal trial of its CE Mark-approved CGuard Carotid Stent System for the prevention of...

July 28, 2020

Features

Soliton seeking FDA okay to treat cellulite with Rapid Acoustic Pulse

Wally Klemp, Executive Chairman Soliton (NASDAQ:SOLY) has filed a 510(k) submission for FDA clearance of its Rapid Acoustic Pulse (RAP) technology for reduction in the appearance of cellulite, which affects between 80%...

July 21, 2020

Features

Loki Therapeutics harnessing antigens from traditional childhood vaccinations for immunotherapy

Unlike the traditional approach to immunotherapy, which teaches the body to recognize tumor antigens as something foreign to be attacked, closely-held Loki Therapeutics’ AWAKE technology makes cancer appear as something...

July 7, 2020

Features

CohBar developing therapeutics from mitochondrial DNA

CohBar (NASDAQ:CWBR) is transforming peptides encoded and expressed by mitochondria, some of which control a wide range of systems in the body, into novel therapeutics. “Harnessing the power of mitochondria biology to...

June 23, 2020

Features

Seven questions for Ian Koenig of Investis Digital about expediting patient recruitment for clinical trials

Ian Koenig, SVP, Life Sciences at Investis Digital In his role as SVP of life sciences, Ian Koenig brings broad experience to Investis Digital in communications strategy, digital marketing, investor relations and...

June 9, 2020

Features

Chris Kaplan of ITG talks up market-making in capital markets

As a VP of Independent Trading Group (ITG), an issuer designated market making firm, Chris Kaplan brings a more institutional approach to provide liquidity for clients with stocks that are thinly traded. ITG, which is...

June 2, 2020

Features

SetPoint Medical developing bioelectric treatment for RA, chronic autoimmune diseases

Closely-held SetPoint Medical is pioneering electric stimulation of the vagus nerve in the neck as a treatment for rheumatoid arthritis (RA) and other chronic autoimmune diseases, such as Crohn’s disease, ulcerative...

May 26, 2020

Features

Spring Bank Pharma may expand R&D with potential COVID-19 agents

After abruptly ending its hepatitis B virus program in January, Spring Bank Pharmaceuticals (NASDAQ:SBPH) is in the early stages of examining whether its family of RIG-I agonists have the potential to attack SARS-CoV-2...

May 19, 2020

Features

COVID-19 presents opportunities and challenges for Field Trip Psychedelics

Despite delays in dosing of patients at its Toronto clinic and building its network of clinics in the U.S. because of COVID-19, closely-held Field Trip Psychedelics is finding opportunities to expand its psychedelic...

May 12, 2020

Features

Daxor targeting blood volume analysis to reduce mortality and ventilator use in ICU

Daxor’s (NYSE American:DXR) BVA-100 blood volume measurement device is helping to open a new front in the battle against COVID-19. “Optimal volume management and knowledge of capillary status is key to survivability...

April 28, 2020

Author - Leonard Zehr

InspireMD advancing global distribution of CGuard EPS carotid stent for stroke prevention; gearing for U.S. pivotal trial

Soliton seeking FDA okay to treat cellulite with Rapid Acoustic Pulse

Loki Therapeutics harnessing antigens from traditional childhood vaccinations for immunotherapy

CohBar developing therapeutics from mitochondrial DNA

Seven questions for Ian Koenig of Investis Digital about expediting patient recruitment for clinical trials

Chris Kaplan of ITG talks up market-making in capital markets

SetPoint Medical developing bioelectric treatment for RA, chronic autoimmune diseases

Spring Bank Pharma may expand R&D with potential COVID-19 agents

COVID-19 presents opportunities and challenges for Field Trip Psychedelics

Daxor targeting blood volume analysis to reduce mortality and ventilator use in ICU

Follow Us

General

More

Sign up for the BioTuesdays weekly newsletter